Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00027885
Status:
COMPLETED
Last Update Posted:
2013-06-17
First Post:
2001-12-07
Brief Title:
Phase II Bevacizumab Tax In Advanced Breast Cancer
Sponsor:
Case Comprehensive Cancer Center
Organization:
Case Comprehensive Cancer Center
Organization Data
Organization:
Case Comprehensive Cancer Center
Class:
OTHER
Study ID:
CWRU3100
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Case Comprehensive Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |